FDAnews
www.fdanews.com/articles/149333-jazz-pharma-agrees-to-sell-women-rsquo-s-health-business

Jazz Pharma Agrees to Sell Women’s Health Business

September 10, 2012
The Irish drugmaker Jazz Pharmaceuticals is selling its women’s health business to specialty pharmaceutical company Meda for $95 million in cash so that it can concentrate on its core products.
Businessweek